Related references
Note: Only part of the references are listed.Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments
R. Kwok et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease
Shobha H. Ganji et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Obstructive Sleep Apnea Syndrome Affects Liver Histology and Inflammatory Cell Activation in Pediatric Nonalcoholic Fatty Liver Disease, Regardless of Obesity/Insulin Resistance
Valerio Nobili et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Omega-3 phospholipids from fish suppress hepatic steatosis by integrated inhibition of biosynthetic pathways in dietary obese mice
Martin Rossmeisl et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease
Meropi D. Kontogianni et al.
CLINICAL NUTRITION (2014)
The Interactions of Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases
Hugo Perazzo et al.
CLINICS IN LIVER DISEASE (2014)
Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease
Valerio Nobili et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Caffeine Stimulates Hepatic Lipid Metabolism by the Autophagy-Lysosomal Pathway in Mice
Rohit A. Sinha et al.
HEPATOLOGY (2014)
Coffee and non-alcoholic fatty liver disease: Brewing evidence for hepatoprotection?
Shaohua Chen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Histological Abnormalities in Children with Nonalcoholic Fatty Liver Disease and Normal or Mildly Elevated Alanine Aminotransferase Levels
Jean P. Molleston et al.
JOURNAL OF PEDIATRICS (2014)
Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease
Hellan K. Kwon et al.
LIVER INTERNATIONAL (2014)
Comparison of contrast-enhanced ultrasonography with grey-scale ultrasonography and contrast-enhanced computed tomography in diagnosing focal fatty liver infiltrations and focal fatty sparing
J. Janica et al.
ADVANCES IN MEDICAL SCIENCES (2013)
Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease
M. D. Beaton et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis
J. H. Hoofnagle et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
PNPLA3/adiponutrin functions in lipid droplet formation
Zeina Chamoun et al.
BIOLOGY OF THE CELL (2013)
The role of Ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review
Zun Xiang et al.
BMC GASTROENTEROLOGY (2013)
Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial
Wojciech Janczyk et al.
BMC PEDIATRICS (2013)
Association Between Variants in or Near PNPLA3, GCKR, and PPP1R3B With Ultrasound-Defined Steatosis Based on Data From the Third National Health and Nutrition Examination Survey
Ruben Hernaez et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Gut microbiota and non-alcoholic fatty liver disease: new insights
J. Aron-Wisnewsky et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Statins in Nonalcoholic Fatty Liver Disease and Steatohepatitis: Updated Review
William Nseir et al.
CURRENT ATHEROSCLEROSIS REPORTS (2013)
Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
Bertrand Cariou et al.
DIABETES CARE (2013)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Association between the Pro12Ala polymorphism of PPAR-γ gene and the non-alcoholic fatty liver disease: A meta-analysis
Jun Wang et al.
GENE (2013)
Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: A study in Brazilian patients
Fernanda Aparecida Domenici et al.
GENE (2013)
The Effect of Pioglitazone and Metformin on Liver Function Tests, Insulin Resistance, and Liver Fat Content in Nonalcoholic Fatty Liver Disease: A Randomized Double Blinded Clinical Trial
Mohsen Razavizade et al.
HEPATITIS MONTHLY (2013)
Hepatoprotective Effects of the Dual Peroxisome Proliferator-Activated Receptor Alpha/Delta Agonist, GFT505, in Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Bart Staels et al.
HEPATOLOGY (2013)
Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal
Mariana V. Machado et al.
JOURNAL OF HEPATOLOGY (2013)
PPARγ signaling and metabolism: the good, the bad and the future
Maryam Ahmadian et al.
NATURE MEDICINE (2013)
Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis
G. Musso et al.
OBESITY REVIEWS (2013)
The Relationship Between Pediatric Nonalcoholic Fatty Liver Disease and Cardiovascular Risk Factors and Increased Risk of Atherosclerosis in Obese Children
Selim Gokce et al.
PEDIATRIC CARDIOLOGY (2013)
Non-alcoholic fatty liver disease and liver transplantation: Outcomes and advances
Adnan Said
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Yan-Yan Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Peroxisome Proliferator-Activated Receptor Genetic Polymorphisms and Nonalcoholic Fatty Liver Disease: Any Role in Disease Susceptibility?
Paola Dongiovanni et al.
PPAR RESEARCH (2013)
Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease
Jose Illnait et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2013)
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Layli Eslami et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Caffeine is protective in patients with non-alcoholic fatty liver disease
A. Birerdinc et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis
E. Boettcher et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
Kouichi Miura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Hepatic mTORC2 Activates Glycolysis and Lipogenesis through Akt, Glucokinase, and SREBP1c
Asami Hagiwara et al.
CELL METABOLISM (2012)
Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population
Maria Stepanova et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression
Karen D. Corbin et al.
CURRENT OPINION IN GASTROENTEROLOGY (2012)
Ursodeoxycholic acid for nonalcoholic steatohepatitis
Sheng-di Wu et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
Naga Chalasani et al.
GASTROENTEROLOGY (2012)
Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study
Yin-Mei Lee et al.
GASTROINTESTINAL ENDOSCOPY (2012)
Effects of Metformin, Pioglitazone, and Silymarin Treatment on Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study
Ali Akbar Hajiaghamohammadi et al.
HEPATITIS MONTHLY (2012)
Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis
Jeffrey W. Molloy et al.
HEPATOLOGY (2012)
Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: A pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study
Lauren N. Bell et al.
HEPATOLOGY (2012)
Ethnicity and nonalcoholic fatty liver disease
Kiran Bambha et al.
HEPATOLOGY (2012)
A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease
Shamsul Mohd Zain et al.
HUMAN GENETICS (2012)
Cardiovascular Disease and Nonalcoholic Fatty Liver Disease Does Histologic Severity Matter?
Jeremy P. Domanski et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage)
Ki Hoon Han et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
Shira Zelber-Sagi et al.
JOURNAL OF HEPATOLOGY (2012)
Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery
Rodolphe Anty et al.
JOURNAL OF HEPATOLOGY (2012)
Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Helen M. Parker et al.
JOURNAL OF HEPATOLOGY (2012)
Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)
Winston Dunn et al.
JOURNAL OF HEPATOLOGY (2012)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
Christian Thoma et al.
JOURNAL OF HEPATOLOGY (2012)
Effect of Bariatric Surgery on Liver Fibrosis
Myriam Moretto et al.
OBESITY SURGERY (2012)
Obstructive Sleep Apnea-Hypopnea Syndrome and Nonalcoholic Fatty Liver Disease: Emerging Evidence and Mechanisms
Giovanni Musso et al.
SEMINARS IN LIVER DISEASE (2012)
Investigation of the Effects of Chlorella Vulgaris Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
Yunes Panahi et al.
HEPATO-GASTROENTEROLOGY (2012)
Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease
Ganesh Bhat et al.
WORLD JOURNAL OF HEPATOLOGY (2012)
Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial
Temitope Foster et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
Giovanni Musso et al.
ANNALS OF MEDICINE (2011)
Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C
Elena Lima-Cabello et al.
CLINICAL SCIENCE (2011)
Lipid droplet meets a mitochondrial protein to regulate adipocyte lipolysis
Andrew S. Greenberg et al.
EMBO JOURNAL (2011)
Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity
Guillaume Lassailly et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation
Georgi Kirovski et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review
D. Shyangdan et al.
HEALTH TECHNOLOGY ASSESSMENT (2011)
Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Losartan in the Treatment of Nonalcoholic Steatohepatitis in Humans: A 12-Month Randomized, Prospective, Open-Label Trial
Dawn M. Torres et al.
HEPATOLOGY (2011)
Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents The TONIC Randomized Controlled Trial
Joel E. Lavine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis
Leon A. Adams et al.
JOURNAL OF DIGESTIVE DISEASES (2011)
Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes
Celine Dubuquoy et al.
JOURNAL OF HEPATOLOGY (2011)
Thematic Review Series: Genetics of Human Lipid Diseases Genetic determinants of hepatic steatosis in man
Amanda J. Hooper et al.
JOURNAL OF LIPID RESEARCH (2011)
Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease
Wenjun Li et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial
Elena Sofer et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Nonalcoholic Steatohepatitis (NASH) Does Not Increase Complications After Laparoscopic Bariatric Surgery
Toby N. Weingarten et al.
OBESITY SURGERY (2011)
Quantification of Hepatic Steatosis with T1-independent, T2*-corrected MR Imaging with Spectral Modeling of Fat: Blinded Comparison with MR Spectroscopy
Sina Meisamy et al.
RADIOLOGY (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in rat hepatocytes
Alexandra Rogue et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
Weight reduction for non-alcoholic fatty liver disease
Lijun Peng et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients
R. Anty et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee
P. Loria et al.
DIGESTIVE AND LIVER DISEASE (2010)
Protective Role of Coffee in Non-alcoholic Fatty Liver Disease (NAFLD)
Daniela Catalano et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients
Rosario Forlano et al.
GASTROINTESTINAL ENDOSCOPY (2010)
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
Vincent Wai-Sun Wong et al.
GUT (2010)
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
Stuart McPherson et al.
GUT (2010)
Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
Kittichai Promrat et al.
HEPATOLOGY (2010)
Long-Term Efficacy of Rosiglitazone in Nonalcoholic Steatohepatitis: Results of the Fatty Liver Improvement by Rosiglitazone Therapy (FLIRT 2) Extension Trial
Vlad Ratziu et al.
HEPATOLOGY (2010)
Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver Disease
Vincent Wai-Sun Wong et al.
HEPATOLOGY (2010)
Increased Fructose Consumption Is Associated with Fibrosis Severity in Patients with Nonalcoholic Fatty Liver Disease
Manal F. Abdelmalek et al.
HEPATOLOGY (2010)
PNPLA3 Variants Specifically Confer Increased Risk for Histologic Nonalcoholic Fatty Liver Disease But Not Metabolic Disease
Elizabeth K. Speliotes et al.
HEPATOLOGY (2010)
Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study
G. A. Garinis et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
Effect of Fenofibrate and Niacin on Intrahepatic Triglyceride Content, Very Low-Density Lipoprotein Kinetics, and Insulin Action in Obese Subjects with Nonalcoholic Fatty Liver Disease
Elisa Fabbrini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes
Alok K. Gupta et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2010)
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2010)
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
Vasilios G. Athyros et al.
LANCET (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A feed-forward loop amplifies nutritional regulation of PNPLA3
Yongcheng Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Novel Insights into the Pathophysiology of Nonalcoholic Fatty Liver Disease
Ariel E. Feldstein
SEMINARS IN LIVER DISEASE (2010)
The Role of Lipid Metabolism in the Pathogenesis of Alcoholic and Nonalcoholic Hepatic Steatosis
Margaret S. Sozio et al.
SEMINARS IN LIVER DISEASE (2010)
Bariatric surgery for non-alcoholic steatohepatitis in obese patients
N. C. Chavaez-Tapia et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
R. Loomba et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease
Yusuf Yilmaz et al.
CLINICAL BIOCHEMISTRY (2009)
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Curtis K. Argo et al.
CLINICS IN LIVER DISEASE (2009)
Diagnostic Value of Serum Prolidase Enzyme Activity to Predict the Liver Histological Lesions in Non-alcoholic Fatty Liver Disease: A Surrogate Marker to Distinguish Steatohepatitis from Simple Steatosis
Huseyin Kayadibi et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Heritability of Nonalcoholic Fatty Liver Disease
Jeffrey B. Schwimmer et al.
GASTROENTEROLOGY (2009)
Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease
Philippe Mathurin et al.
GASTROENTEROLOGY (2009)
Orlistat for Overweight Subjects with Nonalcoholic Steatohepatitis: A Randomized, Prospective Trial
Stephen A. Harrison et al.
HEPATOLOGY (2009)
Nonalcoholic Steatohepatitis in Children: A Multicenter Clinicopathological Study
Christine Carter-Kent et al.
HEPATOLOGY (2009)
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers The Selenium and Vitamin E Cancer Prevention Trial ( SELECT)
Scott M. Lippman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy
Andrea J. Cussons et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis A Randomized Placebo-controlled Trial
Austin Nelson et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis
Robert K. Semple et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome
Ali Abid et al.
JOURNAL OF HEPATOLOGY (2009)
Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance
Nina F. Schwenzer et al.
JOURNAL OF HEPATOLOGY (2009)
Hepatic triacylglycerol accumulation and insulin resistance
Cynthia A. Nagle et al.
JOURNAL OF LIPID RESEARCH (2009)
Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores
Rudolf Zechner et al.
JOURNAL OF LIPID RESEARCH (2009)
Assessing the potential of glucokinase activators in diabetes therapy
Franz M. Matschinsky
NATURE REVIEWS DRUG DISCOVERY (2009)
Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers
M. A. Edens et al.
OBESITY REVIEWS (2009)
Continuous Positive Airway Pressure and Liver Enzymes in Obstructive Sleep Apnoea: Data from a Randomized Controlled Trial
Malcolm Kohler et al.
RESPIRATION (2009)
Nonalcoholic fatty liver disease in children living in the obeseogenic society
H. Hesham A-Kader
WORLD JOURNAL OF PEDIATRICS (2009)
The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial
William W. Shields et al.
Therapeutic Advances in Gastroenterology (2009)
Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis
Anna Wieckowska et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)
Masato Yoneda et al.
BMC GASTROENTEROLOGY (2008)
Selective versus total insulin resistance: A pathogenic paradox
Michael S. Brown et al.
CELL METABOLISM (2008)
Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome
Chin Hee Kim et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2008)
Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Rajasekhara R. Mummadi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease
C. Fernandez-Miranda et al.
DIGESTIVE AND LIVER DISEASE (2008)
Rosiglitazone for nonalcoholic steatohepatitis: One-year results of the randomized placebo-controlled fatty liver improvement with rosiglitazone therapy (FLIRT) trial
Vlad Ratziu et al.
GASTROENTEROLOGY (2008)
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
Guruprasad P. Aithal et al.
GASTROENTEROLOGY (2008)
Performance of transient elastography for the staging of liver fibrosis: A meta-analysis
Mireen Friedrich-Rust et al.
GASTROENTEROLOGY (2008)
Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
S. A. Harrison et al.
GUT (2008)
Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease
Winston Dunn et al.
HEPATOLOGY (2008)
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
Anna Ludovica Fracanzani et al.
HEPATOLOGY (2008)
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Janus P. Ong et al.
JOURNAL OF HEPATOLOGY (2008)
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Xiaosen Ouyang et al.
JOURNAL OF HEPATOLOGY (2008)
Non-alcoholic fatty liver disease: The mist gradually clears
Nimantha Mark Wilfred de Alwis et al.
JOURNAL OF HEPATOLOGY (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Bariatric Therapy with Intragastric Balloon Improves Liver Dysfunction and Insulin Resistance in Obese Patients
Giorgio Ricci et al.
OBESITY SURGERY (2008)
Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to Hyperlipidemia in glycogen storage disease type 1
Robert H. J. Bandsma et al.
PEDIATRIC RESEARCH (2008)
A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance
Guadalupe Sabio et al.
SCIENCE (2008)
Adipokines and cytokines in non-alcoholic fatty liver disease
M. H. Jarrar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Review article:: non-alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery
R. J. J. De Ridder et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials
A. Michael Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis
Masahiko Shimada et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH
Masato Yoneda et al.
JOURNAL OF GASTROENTEROLOGY (2007)
Correlation of serum TNF-α levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease
Melania Manco et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
CGI-58 facilitates lipolysis on lipid droplets but is not involved in the vesiculation of lipid droplets caused by hormonal stimulation
Tomohiro Yamaguchi et al.
JOURNAL OF LIPID RESEARCH (2007)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs
Simon Whalley et al.
CLINICAL MEDICINE (2007)
The liver X receptor (LXR) and hepatic lipogenesis - The carbohydrate-response element-binding protein is a target gene of LXR
Ji-Young Cha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The physiological and molecular regulation of lipoprotein assembly and secretion
Daniel A. Blasiole et al.
MOLECULAR BIOSYSTEMS (2007)
Dietary habits and nutrient intake in non-alcoholic steatohepatitis
Kumiko Toshimitsu et al.
NUTRITION (2007)
Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease
Thierry Poynard et al.
BMC GASTROENTEROLOGY (2006)
Prevalence of fatty liver in children and adolescents
Jeffrey B. Schwimmer et al.
PEDIATRICS (2006)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
ChREBP•Mlx is the principal mediator of glucose-induced gene expression in the liver
Lin Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Metabolic and adipokine profile of chinese patients with nonalcoholic fatty liver disease
Vincent Wai-Sun Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
A choline-deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high-fat diet
Peter J. Raubenheimer et al.
DIABETES (2006)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
John Willy Haukeland et al.
JOURNAL OF HEPATOLOGY (2006)
A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients
E. Gomez-Dominguez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Adipose triglyceridelipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome
Achim Lass et al.
CELL METABOLISM (2006)
Macrovesicular hepatic steatosis in living liver donors: Use of CT for quantitative and qualitative assessment
SH Park et al.
RADIOLOGY (2006)
Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair
XL Jin et al.
HEPATOLOGY (2006)
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
V Ratziu et al.
BMC GASTROENTEROLOGY (2006)
Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis
S Abiru et al.
LIVER INTERNATIONAL (2006)
Blood oxidative stress markers are unreliable markers of hepatic steatosis
D Bonnefont-Rousselot et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome
Dominique Langin
PHARMACOLOGICAL RESEARCH (2006)
Nonalcoholic steatohepatitis and the metabolic syndrome
BA Neuschwander-Tetri
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2005)
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
M Hamaguchi et al.
ANNALS OF INTERNAL MEDICINE (2005)
The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease
E Hashimoto et al.
HEPATOLOGY RESEARCH (2005)
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity
E Bugianesi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease
E Bugianesi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Dietary fat content modifies liver fat in overweight nondiabetic subjects
J Westerbacka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
New hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis
MV Chakravarthy et al.
CELL METABOLISM (2005)
Histologic variation of grade and stage of nonalcoholic fatty liver disease in liver biopsies
DJ Janiec et al.
OBESITY SURGERY (2005)
Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality
ER Miller et al.
ANNALS OF INTERNAL MEDICINE (2005)
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
LA Adams et al.
JOURNAL OF HEPATOLOGY (2005)
Chronological development of elevated aminotransferases in a nonalcoholic population
A Suzuki et al.
HEPATOLOGY (2005)
High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD
JM Hui et al.
HEPATOLOGY (2004)
Genetics of familial combined hyperlipidemia and risk of coronary heart disease
CC Shoulders et al.
HUMAN MOLECULAR GENETICS (2004)
Natural history of nonalcoholic steatohepatitis:: A longitudinal study of repeat liver biopsies
E Fassio et al.
HEPATOLOGY (2004)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Beyond insulin resistance in NASH:: TNF-α or adiponectin?
JM Hui et al.
HEPATOLOGY (2004)
The gut microbiota as an environmental factor that regulates fat storage
F Bäckhed et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Fatty liver in familial hypobetalipoproteinemia:: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity
T Tanoli et al.
JOURNAL OF LIPID RESEARCH (2004)
Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E
M Kugelmas et al.
HEPATOLOGY (2003)
Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice
PJ Klover et al.
DIABETES (2003)
Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients
J Crespo et al.
HEPATOLOGY (2001)
A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver
H Yamashita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
AJ Sanyal et al.
GASTROENTEROLOGY (2001)
Current concepts: Liver biopsy.
AA Bravo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
L Chao et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
